According to Grifols's latest financial reports the company's total debt is $11.68 B. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2022-12-31 | $10.44 B | -1.11% |
2021-12-31 | $10.55 B | 24.22% |
2020-12-31 | $8.50 B | 6.78% |
2019-12-31 | $7.96 B | 98208.43% |
2018-12-31 | $8.09 M | -99.89% |
2017-12-31 | $7.21 B | 40.33% |
2016-12-31 | $5.14 B | -1.17% |
2015-12-31 | $5.20 B | 0.96% |
2014-12-31 | $5.15 B | 38.76% |
2013-12-31 | $3.71 B | 1.07% |
2012-12-31 | $3.67 B | -4.19% |
2011-12-31 | $3.83 B | 236.46% |
2010-12-31 | $1.13 B | -2.63% |
2009-12-31 | $1.17 B | 76.03% |
2008-12-31 | $0.66 B | 21.97% |
2007-12-31 | $0.54 B | 22.34% |
2006-12-31 | $0.44 B | 28.47% |
2005-12-31 | $0.34 B |
Company | Total debt | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $29.33 B | 151.09% | ๐บ๐ธ USA |
Amgen AMGN | $64.61 B | 453.11% | ๐บ๐ธ USA |
Baxter BAX | $14.36 B | 22.96% | ๐บ๐ธ USA |
Kimberly-Clark KMB | $8.11 B | -30.54% | ๐บ๐ธ USA |